Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
International Journal of Medicinal Mushrooms
Facteur d'impact: 1.423 Facteur d'impact sur 5 ans: 1.525 SJR: 0.431 SNIP: 0.716 CiteScore™: 2.6

ISSN Imprimer: 1521-9437
ISSN En ligne: 1940-4344

Volumes:
Volume 22, 2020 Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v1.i3.90
pages 263-282

Cultivation of the Medicinal Mushroom Ganoderma lucidum (Curt.:Fr.)P. Karst. (Reishi) in North America

Alice W. Chen
Specialty Mushrooms, 1730 Penfield Rd., No.41, Penfield, NY 14526, USA

RÉSUMÉ

In contrast to the long Chinese history of cultivation of Ganoderma species (ling zhi/reishi), the most important medicinal mushroom in China, growing reishi is a fairly new adventure in North America. In the past decade or so, increasing awareness of the potential health benefits of Ganoderma species led to production of this medicinal mushroom in the United States and Canada. Such interest was triggered primarily by the immune-enhancing property of the mushroom in integrated therapies for immune deficiency syndrome and cancer. In pharmacological studies in the United States, the search for effective antiinflammatory agents for safe long-term use was directed to this ancient medicinal mushroom. Western herbalists took initiatives in studying and using Ganoderma lucidum (Curt.:Fr.P. Karst.) and other species. Growers across the Pacific Ocean chose almost exclusively G. lucidum as the species for cultivation. North American Ganoderma growers are characterized on the basis of product orientation. Features of emerging North American growers are described. Methodology used in Ganoderma cultivation in North America is illustrated, focusing on synthetic log and natural log cultivation. Highlighted is the successful commercial-scale operation of Organotech in San Antonio, Texas. As a reference for growers, stepwise cultivation technology and crop management is covered.


Articles with similar content:

Mixed-Culture Cultivation of Edible and Medicinal Mushroom Tremella fudformis Berk. (Phragmobasidiomycetes) on Synthetic Logs
International Journal of Medicinal Mushrooms, Vol.4, 2002, issue 4
Nian Lai Huang, Alice W. Chen
Antipox Properties of Fomitopsis officinalis (Vill.: Fr.) Bond. et Singer (Agarikon) from the Pacific Northwest of North America
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Paul E. Stamets
Evaluation of Nanocarrier-Based Dry Powder Formulations for Inhalation with Special Reference to Anti-Tuberculosis Drugs
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.36, 2019, issue 3
Pravin K. Shende, Shirish Deshpande, Ashwini Deshpande, Tulshidas S. Patil, Ram Gaud
Cultivation of the Edible and Medicinal Mushroom Grifola frondosa (Dicks.:Fr.) S. F. Gray (Maitake)—Relevance of Literature to Production in Australia (Review)
International Journal of Medicinal Mushrooms, Vol.5, 2003, issue 2
Karen Stott
Comparative Analysis of Triterpene Composition between Ganoderma lingzhi from China and G. lucidum from Slovakia under Different Growing Conditions
International Journal of Medicinal Mushrooms, Vol.22, 2020, issue 8
Qingjiu Tang, Andrej Kunca, Martin Pavlik, Daniel Kurjak, Jingsong Zhang, Shuai Zhou, Martin Pavlík Jr, Na Feng